Visa (NYSE:V) said on August 3 that it would buy fraud intelligence provider BioCatch for $2.4 billion in cash, its latest move to build out cybersecurity tools for the banks and merchants that run on its network. The deal targets a problem that keeps getting more expensive: account takeovers and scams now cost the global economy more than $1 trillion a year, and Visa says AI is helping fraudsters pull those attacks off at a scale banks have not seen before.
The Bull Case: Closing The Fraud-Tech Gap
BioCatch, founded in 2011 in Tel Aviv, built its business on behavioral biometrics, tracking keystrokes, touch gestures and device handling to tell a real customer apart from a fraudster in real time. It already protects 1.8 billion devices and 760 million users across more than 350 banking clients in 21 countries, and under Permira’s ownership since 2024, its revenue and gross profit both roughly tripled. Folding that into Visa’s rails, which connect nearly 14,500 financial institutions and process more than 329 billion transactions worth over $17 trillion a year, gives the technology a far bigger stage than it had on its own.
The deal also closes a gap investors had been watching. Evercore analyst Adam Frisch said the market would welcome the news, noting that many had pointed to Mastercard’s Recorded Future as the best-in-class tool in this category. Visa has now put real money behind catching up, on top of the more than $13 billion it has spent on technology and infrastructure to fight fraud over the past five years, including its 2024 purchase of Featurespace. Andrew Torre, Visa’s president of value-added services, said BioCatch will help clients stop fraud before it reaches the point of payment, a division that grew revenue 34% last quarter, the fastest-growing part of Visa’s business.
The Bear Case: The Clock And The Competition
The timeline cuts against the urgency of the pitch. The BioCatch deal is not expected to close until the end of Visa’s fiscal second quarter of 2027, so the gap Frisch described stays open for months while Mastercard’s Recorded Future, in place since a $2.65 billion purchase in 2024, keeps running.
On the same day Visa announced the BioCatch purchase, Mastercard (NYSE:MA) completed its own acquisition of stablecoin infrastructure platform BVNK, and on July 23 it rolled out new issuer and clearing controls across its virtual card network, with Citi the first bank live on both. Visa’s underlying business still runs at a wider margin and a slightly higher cross-border volume growth rate (13% to Mastercard’s 12%) last quarter, but Mastercard continues to carve out strong momentum elsewhere, led by a 20% jump in value-added services revenue. None of that is derailed by a single acquisition, and $2.4 billion in cash still has to clear regulators before it changes either company’s fraud numbers.
Market Sentiment: Visa Vs. Mastercard
Both card networks are leaning on acquisitions to build out their security and infrastructure stacks at once. Mastercard completed its BVNK stablecoin deal as Visa announced BioCatch, and its virtual card security push landed two weeks earlier, so investors are pricing two companies making parallel bets rather than one chasing the other. Hedge fund ownership of Visa fell from 184 to 181 funds last quarter, while Mastercard funds rose from 150 to 157, a split in institutional conviction that favors Mastercard’s momentum. As of August 4, Visa trades at a forward P/E of 24.45 versus Mastercard’s 29.15, so the market is asking Mastercard to prove more growth. Short interest sits at 1.39% of Visa’s float against 1.04% for Mastercard.
Conclusion
The BioCatch deal gives Visa a meaningful position in fraud prevention at a time when its cross-border and value-added services businesses are already growing strongly. Mastercard’s recent earnings growth has outpaced Visa’s, but the $2.4 billion acquisition still needs to demonstrate that AI fraud detection can translate into material revenue and attractive returns. Until then, BioCatch strengthens Visa’s long-term payments strategy more clearly than it changes the company’s near-term financial outlook.
While we acknowledge the risk and potential of V and MA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than V and MA and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Disclosure: None. Follow Insider Monkey on Google News.
Hedge Fund Resource Center